Skip to main content

Umbrella menu

  • SfN.org
  • eNeuro
  • The Journal of Neuroscience
  • Neuronline
  • BrainFacts.org

Main menu

  • HOME
  • CONTENT
    • Early Release
    • Featured
    • Current Issue
    • Issue Archive
    • Collections
  • ALERTS
  • FOR AUTHORS
    • Preparing a Manuscript
    • Submission Guidelines
    • Fees
    • Journal Club
    • eLetters
    • Submit
  • EDITORIAL BOARD
  • ABOUT
    • Overview
    • Advertise
    • For the Media
    • Rights and Permissions
    • Privacy Policy
    • Feedback
  • SUBSCRIBE
  • SfN.org
  • eNeuro
  • The Journal of Neuroscience
  • Neuronline
  • BrainFacts.org

User menu

  • Log in
  • Subscribe
  • My alerts
  • My Cart

Search

  • Advanced search
Journal of Neuroscience
  • Log in
  • Subscribe
  • My alerts
  • My Cart
Journal of Neuroscience

Advanced Search

Submit a Manuscript
  • HOME
  • CONTENT
    • Early Release
    • Featured
    • Current Issue
    • Issue Archive
    • Collections
  • ALERTS
  • FOR AUTHORS
    • Preparing a Manuscript
    • Submission Guidelines
    • Fees
    • Journal Club
    • eLetters
    • Submit
  • EDITORIAL BOARD
  • ABOUT
    • Overview
    • Advertise
    • For the Media
    • Rights and Permissions
    • Privacy Policy
    • Feedback
  • SUBSCRIBE
PreviousNext
Articles, Behavioral/Cognitive

Slack Channels Expressed in Sensory Neurons Control Neuropathic Pain in Mice

Ruirui Lu, Anne E. Bausch, Wiebke Kallenborn-Gerhardt, Carsten Stoetzer, Natasja Debruin, Peter Ruth, Gerd Geisslinger, Andreas Leffler, Robert Lukowski and Achim Schmidtko
Journal of Neuroscience 21 January 2015, 35 (3) 1125-1135; DOI: https://doi.org/10.1523/JNEUROSCI.2423-14.2015
Ruirui Lu
1Institut für Pharmakologie und Toxikologie, Universität Witten/Herdecke, Zentrum für Biomedizinische Ausbildung und Forschung, 58453 Witten, Germany,
2Pharmazentrum Frankfurt/Zentrum für Arzneimittelforschung, Entwicklung und Sicherheit, Institut für Klinische Pharmakologie, Universitätsklinikum Frankfurt, 60590 Frankfurt am Main, Germany,
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Anne E. Bausch
3Pharmakologie, Toxikologie und Klinische Pharmazie, Institut für Pharmazie, 72076 Tübingen, Germany,
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Wiebke Kallenborn-Gerhardt
2Pharmazentrum Frankfurt/Zentrum für Arzneimittelforschung, Entwicklung und Sicherheit, Institut für Klinische Pharmakologie, Universitätsklinikum Frankfurt, 60590 Frankfurt am Main, Germany,
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Carsten Stoetzer
4Klinik für Anästhesiologie und Intensivmedizin, Medizinische Hochschule Hannover, 30625 Hannover, Germany, and
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Natasja Debruin
5Fraunhofer Institute for Molecular Biology and Applied Ecology IME, 60590 Frankfurt am Main, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Peter Ruth
3Pharmakologie, Toxikologie und Klinische Pharmazie, Institut für Pharmazie, 72076 Tübingen, Germany,
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Gerd Geisslinger
2Pharmazentrum Frankfurt/Zentrum für Arzneimittelforschung, Entwicklung und Sicherheit, Institut für Klinische Pharmakologie, Universitätsklinikum Frankfurt, 60590 Frankfurt am Main, Germany,
5Fraunhofer Institute for Molecular Biology and Applied Ecology IME, 60590 Frankfurt am Main, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Andreas Leffler
4Klinik für Anästhesiologie und Intensivmedizin, Medizinische Hochschule Hannover, 30625 Hannover, Germany, and
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Robert Lukowski
3Pharmakologie, Toxikologie und Klinische Pharmazie, Institut für Pharmazie, 72076 Tübingen, Germany,
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Achim Schmidtko
1Institut für Pharmakologie und Toxikologie, Universität Witten/Herdecke, Zentrum für Biomedizinische Ausbildung und Forschung, 58453 Witten, Germany,
2Pharmazentrum Frankfurt/Zentrum für Arzneimittelforschung, Entwicklung und Sicherheit, Institut für Klinische Pharmakologie, Universitätsklinikum Frankfurt, 60590 Frankfurt am Main, Germany,
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF
Loading

Article Figures & Data

Figures

  • Figure 1.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Figure 1.

    Genetic ablation of the pore-forming exon of the murine Kcnt1 gene in ES cells. A, Murine WT Kcnt1 locus with exon 11 encoding the pore (P, red box) and surrounding exons 5–19 (black boxes) including relevant restriction sites (top). In ES cells, a single loxP recombination site (triangle) and a floxed neo/tk-cassette were introduced into the 3′-intronic and 5′-intronic regions flanking exon 11 (P) by homologous recombination resulting in the Slack L3-allele. L2 ES cells with floxed pore exons were generated by Cre recombinase-mediated excision of the selection cassette. L2 ES cells were injected into C57BL/6 blastocysts to obtain the L2/+ mouse line as described in Materials and Methods. Germline excision of the pore exon (L1) was conducted in mice by crossing Slack L2/+ animals to the Cre deleter mouse strain. Selected probes, restriction sites, and fragment sizes for the identification of the correct L3, L2, and L1 alleles by Southern blot in ES cells are shown. B, Verification of correct homologous and Cre recombination in ES cells by Southern blot analyses using the different probes. C, Representative example of a genotyping PCR using genomic DNA from mouse tail-tip biopsies as templates. D, The absence of the pore-forming exon was further verified by reverse transcription PCR analyses on total RNA isolated from cerebral cortex of Slack−/− mice using a pore exon-specific primer pair.

  • Figure 2.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Figure 2.

    Expression of Slack channels in DRG neurons. A, Immunofluorescence of Slack in lumbar DRGs of WT and Slack−/− mice revealed specific Slack expression in 31.6 ± 1.7% (2571 cells counted, n = 3 mice) of DRG neurons. B, Western blot analysis of Slack (140 kDa) in DRG homogenates of WT and Slack−/− mice confirms the specificity of the anti-Slack antibody. GAPDH (36 kDa) was used as loading control. C, D, Typical examples of Slack immunoreactivity in nociceptor subpopulations positive for IB4 and CGRP. E, Quantitative summary of DRG neuron populations expressing Slack. Most Slack-positive cells bind IB4 (86.5 ± 1.6%, 2108 cells counted, n = 3 mice) and are therefore nonpeptidergic, whereas a few Slack-positive cells colocalize with CGRP in peptidergic DRG neurons (12.6 ± 0.33%, 1114 cells counted, n = 3 mice). F, Size distribution of Slack-positive DRG neurons compared with those expressing IB4, CGRP, and neurofilament 200 (NF200), a marker of large myelinated DRG neurons. The data demonstrate that Slack channels are nearly exclusively expressed in nociceptive DRG neurons of small and medium diameter. Scale bars, 50 μm.

  • Figure 3.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Figure 3.

    Expression of Slack channels in the spinal cord. A, Immunofluorescence of Slack in the lumbar spinal cord of WT and Slack−/− mice reveals specific Slack expression in the superficial dorsal horn. B, Western blot analysis of Slack (140 kDa) in spinal cord homogenates of WT and Slack−/− mice confirms the specificity of the anti-Slack antibody. GAPDH (36 kDa) was used as loading control. C, Colocalization of Slack with IB4 shows that Slack channels are present in central terminals of sensory neurons entering the superficial dorsal horn. Scale bars, 100 μm.

  • Figure 4.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Figure 4.

    Slack generates KNa and regulates AP firing in sensory neurons. A, B, Representative current traces from whole-cell voltage-clamp recordings on IB4-positive WT (n = 17) and Slack−/− (n = 16) DRG neurons monitoring outward K+ currents in presence of 140 mm NaCl (black traces) and after replacement of NaCl with 140 mm choline chloride (red traces). Currents were elicited by protocols consisting of 1000-ms-long test pulses ranging from −80 to +110 mV in steps of 10 mV. Holding potential was −70 mV. All neurons were first recorded in presence of NaCl. To visualize the KNa current, the current traces obtained with 140 mm NaCl and 140 mm choline chloride were digitally subtracted and depicted as green traces. Please note that the absence of extracellular Na+ was verified by the lack of Na+ inward currents (red traces). C, Representative current traces from whole-cell current-clamp recordings on IB4-positive WT (n = 21) and Slack−/− (n = 22) DRG neurons. APs were elicited by 1000 ms current injections corresponding to 2–3 times the threshold of a single AP. Pictured are three observed patterns of AP firing during the current injection, i.e., no accommodation (left), accommodation (middle), and strong accommodation without repetitive firing (right). D, Percentage of DRG neurons from WT and Slack−/− mice generating outward K+ currents (KNa). E, Mean KNa current amplitudes in DRG neurons from WT (n = 8) and Slack−/− (n = 2) mice. F, Percentage of DRG neurons from WT and Slack−/− mice generating APs without accommodation, i.e., cells with repetitive firing of APs. *p < 0.05.

  • Figure 5.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Figure 5.

    Basal sensitivity is normal in Slack−/− mice. A, B, Mechanical pain sensitivity was measured using the dynamic plantar (A; n = 15–17/genotype) and the Randall-Selitto tests (B; n = 8/genotype). C, D, Thermal heat pain sensitivity was assessed by tail-flick (C; n = 8/genotype) and hot plate tests (D; n = 14/genotype). E, Cold pain sensitivity was investigated on a 0°C cold plate (n = 14/genotype). No significant differences were observed between Slack−/− and WT mice in any of these tests.

  • Figure 6.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Figure 6.

    Increased neuropathic pain behavior in Slack−/− mice. A, B, Paw-withdrawal latencies of Slack−/− and WT mice after mechanical stimulation in the SNI model (n = 8/genotype; A) and the paclitaxel model (2 mg/kg, i.p., for 5 consecutive days; n = 8–9/genotype; B) of neuropathic pain. Slack−/− mice demonstrated increased mechanical hypersensitivity compared with WT littermates. *p < 0.05, WT versus Slack−/−, repeated-measures ANOVA with Bonferroni's post hoc test.

  • Figure 7.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Figure 7.

    Increased neuropathic pain behavior after conditional deletion of Slack channels in sensory neurons. A, Double-labeling immunostaining revealed that virtually all Slack-positive DRG neurons are also positive for NaV1.8. B, Slack immunofluorescence was not detectable in DRGs of SNS-Slack−/− mice, in which the Cre/loxP-mediated recombination of the Slack encoding gene Kcnt1 occurred in NaV1.8-positive sensory neurons. C, Western blot analysis demonstrated that Slack expression was considerably reduced in the spinal cord but normal in the brain of SNS-Slack−/− mice. GAPDH was used as loading control. D, Paw-withdrawal latencies of SNS-Slack−/− and SNS-Ctrl mice after mechanical stimulation in the SNI model of neuropathic pain (n = 8/genotype). SNS-Slack−/− mice demonstrated increased mechanical hypersensitivity compared with SNS-Ctrl mice. *p < 0.05, WT versus Slack−/−, repeated-measures ANOVA with Bonferroni's post hoc test. Scale bars, 50 μm.

  • Figure 8.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Figure 8.

    Intrathecal (i.t.) NAD+ ameliorates neuropathic pain in a Slack-dependent manner. Animals were subjected to SNI to induce neuropathic pain, and NAD+ was intrathecally administered 14 d thereafter. Time courses of paw-withdrawal latencies after mechanical stimulation (n = 7–8/genotype). *p < 0.05, before NAD+ injection (“after SNI”) versus after NAD+ injection in WT mice, repeated-measures ANOVA with Dunnett's post hoc test.

  • Figure 9.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Figure 9.

    Loxapine ameliorates neuropathic pain in a Slack-dependent manner. A–C, Neuropathic pain was induced in WT and Slack−/− mice by SNI surgery. Fourteen days thereafter, animals were intraperitoneally injected with loxapine (A; n = 12–13/genotype), olanzapine (B; n = 7–8/genotype), or pregabalin (C; n = 7/genotype), and the mechanical paw-withdrawal latencies were assessed over 6 h. Note that loxapine inhibited the neuropathic pain behavior in WT but not in Slack−/− mice, whereas olanzapine did not affect the pain behavior in both genotypes. Pregabalin was used as a positive control. *#p < 0.05, before drug injection (“after SNI”) versus after drug injection in WT and Slack−/− mice, respectively; repeated-measures ANOVA with Bonferroni's post hoc test.

  • Figure 10.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Figure 10.

    Inflammatory pain behavior is normal in Slack−/− mice. A, B, Formalin test. A, The time course of paw licking induced by 0.5% formalin injection was similar between Slack−/− and WT mice. B, Statistical analyses revealed no significant differences in the first (1–10 min) and the second (11–45 min) phase of paw licking (n = 6/genotype). C, Zymosan model. Paw-withdrawal latencies after mechanical stimulation after injection of zymosan into a hindpaw did not differ between genotypes (n = 7–8/genotype). D, The zymosan-induced mechanical hypersensitivity in WT mice was not affected by intraperitoneal administration of the Slack channel opener loxapine (0.175 mg/kg) 3 h after zymosan injection (n = 8/genotype).

Back to top

In this issue

The Journal of Neuroscience: 35 (3)
Journal of Neuroscience
Vol. 35, Issue 3
21 Jan 2015
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover
  • Index by author
  • Advertising (PDF)
  • Ed Board (PDF)
Email

Thank you for sharing this Journal of Neuroscience article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
Slack Channels Expressed in Sensory Neurons Control Neuropathic Pain in Mice
(Your Name) has forwarded a page to you from Journal of Neuroscience
(Your Name) thought you would be interested in this article in Journal of Neuroscience.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Print
View Full Page PDF
Citation Tools
Slack Channels Expressed in Sensory Neurons Control Neuropathic Pain in Mice
Ruirui Lu, Anne E. Bausch, Wiebke Kallenborn-Gerhardt, Carsten Stoetzer, Natasja Debruin, Peter Ruth, Gerd Geisslinger, Andreas Leffler, Robert Lukowski, Achim Schmidtko
Journal of Neuroscience 21 January 2015, 35 (3) 1125-1135; DOI: 10.1523/JNEUROSCI.2423-14.2015

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Respond to this article
Request Permissions
Share
Slack Channels Expressed in Sensory Neurons Control Neuropathic Pain in Mice
Ruirui Lu, Anne E. Bausch, Wiebke Kallenborn-Gerhardt, Carsten Stoetzer, Natasja Debruin, Peter Ruth, Gerd Geisslinger, Andreas Leffler, Robert Lukowski, Achim Schmidtko
Journal of Neuroscience 21 January 2015, 35 (3) 1125-1135; DOI: 10.1523/JNEUROSCI.2423-14.2015
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • Introduction
    • Materials and Methods
    • Results
    • Discussion
    • Footnotes
    • References
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF

Keywords

  • analgesia
  • dorsal root ganglion
  • neuropathic pain
  • Slack channel

Responses to this article

Respond to this article

Jump to comment:

No eLetters have been published for this article.

Related Articles

Cited By...

More in this TOC Section

Articles

  • Neural Stem Cell Transplantation Induces Stroke Recovery by Upregulating Glutamate Transporter GLT-1 in Astrocytes
  • Memory Retrieval Has a Dynamic Influence on the Maintenance Mechanisms That Are Sensitive to ζ-Inhibitory Peptide (ZIP)
  • Stimulation of PPC Affects the Mapping between Motion and Force Signals for Stiffness Perception But Not Motion Control
Show more Articles

Behavioral/Cognitive

  • Evaluating Visual Cues Modulates Their Representation in Mouse Visual and Cingulate Cortex
  • Computational and Neurobiological Substrates of Cost-Benefit Integration in Altruistic Helping Decision
  • Tracking Age Differences in Neural Distinctiveness across Representational Levels
Show more Behavioral/Cognitive
  • Home
  • Alerts
  • Visit Society for Neuroscience on Facebook
  • Follow Society for Neuroscience on Twitter
  • Follow Society for Neuroscience on LinkedIn
  • Visit Society for Neuroscience on Youtube
  • Follow our RSS feeds

Content

  • Early Release
  • Current Issue
  • Issue Archive
  • Collections

Information

  • For Authors
  • For Advertisers
  • For the Media
  • For Subscribers

About

  • About the Journal
  • Editorial Board
  • Privacy Policy
  • Contact
  • Feedback
(JNeurosci logo)
(SfN logo)

Copyright © 2021 by the Society for Neuroscience.
JNeurosci Online ISSN: 1529-2401

The ideas and opinions expressed in JNeurosci do not necessarily reflect those of SfN or the JNeurosci Editorial Board. Publication of an advertisement or other product mention in JNeurosci should not be construed as an endorsement of the manufacturer’s claims. SfN does not assume any responsibility for any injury and/or damage to persons or property arising from or related to any use of any material contained in JNeurosci.